Xiao-Mei Mo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Xiao-Mei Mo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Huahui Li
Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices
2 shared publications - Fenghai Liu
Department of Magnetic Resonance Imaging, Cangzhou Central Hospital, Cangzhou City, China
1 shared publication - George Yuhui Chen
Shenzhen University
1 shared publication - Guanhua Liang
Shandong Second Medical University, Weifang, China
1 shared publication - Hui Liang
Department of Urology, The Longhua Affiliated Hospital (The People's Hospital of Longhua), School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518109, P.R. China
1 shared publication - Jianmin Liu
Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 1 July 2025
- Published by BMJ in BMJ Open Quality
- Vol. 14 (3) , e003392
Fatal anaphylactic shock following cefoperazone–sulbactam re-exposure: a short report on systemic gaps in adverse drug reaction management
This report presents a case of fatal anaphylactic shock following re-exposure to cefoperazone-sulbactam, highlighting systemic gaps in adverse drug reaction (ADR) management. The patient initially tolerated the drug without immediate adverse effects but developed severe hypersensitivity reactions upon subsequent exposures, ultimately leading to death. Analysis revealed that the healthcare team underestimated the risk of delayed IgE-mediated sensitization, and critical allergy information was not documented in the emergency department (ED). Additionally, the electronic health record (EHR) system lacked real-time allergy alerts. Fragmented communication during care transitions and technological deficiencies further exacerbated the risks.
- 1 July 2025
- Published by BMJ in BMJ Open Quality
- Vol. 14 (3) , e003392
Open AccessFatal anaphylactic shock following cefoperazone–sulbactam re-exposure: a short report on systemic gaps in adverse drug reaction management
This report presents a case of fatal anaphylactic shock following re-exposure to cefoperazone-sulbactam, highlighting systemic gaps in adverse drug reaction (ADR) management. The patient initially tolerated the drug without immediate adverse effects but developed severe hypersensitivity reactions upon subsequent exposures, ultimately leading to death. Analysis revealed that the healthcare team underestimated the risk of delayed IgE-mediated sensitization, and critical allergy information was not documented in the emergency department (ED). Additionally, the electronic health record (EHR) system lacked real-time allergy alerts. Fragmented communication during care transitions and technological deficiencies further exacerbated the risks.
- 1 August 2016
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 431, 71-87
Up-regulation of Hsp27 by ERα/Sp1 facilitates proliferation and confers resistance to apoptosis in human papillary thyroid cancer cells
- 1 August 2016
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 431, 71-87
Up-regulation of Hsp27 by ERα/Sp1 facilitates proliferation and confers resistance to apoptosis in human papillary thyroid cancer cells
- Open Access
- 12 January 2016
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 13 (3) , 1961-1966
MicroRNA-610 suppresses the proliferation of human glioblastoma cells by repressing CCND2 and AKT3
Previous studies have shown that microRNA (miR)-610 is crucial in a variety of biological processes in various types of human cancer cells. However, the role of this microRNA in glioblastoma (GBM) is presently unclear. In this study, the role of miR‑610 in cell proliferation was investigated in GBM. It was demonstrated that miR‑610 expression is markedly downregulated in GBM cells and GBM tissues compared with normal human astrocytes (NHAs) and normal brain tissue, respectively. Ectopic expression of miR‑610 reduced the proliferation and anchorage‑independent growth of GBM cells, whereas inhibition of miR‑610 promoted this effect. Bioinformatics analysis further revealed cyclin D2 (CCND2) and AKT3, putative tumor promoters, as potential targets of miR‑610. Data from reporter assays showed that miR‑610 directly binds to the 3'‑untranslated region of CCND2 and AKT3 mRNA, and represses their expression at the transcriptional and translational levels. In conclusion, the data provide compelling evidence that miR‑610 functions as an anti‑onco‑miRNA, which is important in inhibiting cell proliferation in GBM, and its anti‑oncogenic effects are mediated chiefly through direct suppression of CCND2 and AKT3 expression.
- 12 January 2016
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 13 (3) , 1961-1966
Open AccessMicroRNA-610 suppresses the proliferation of human glioblastoma cells by repressing CCND2 and AKT3
Previous studies have shown that microRNA (miR)-610 is crucial in a variety of biological processes in various types of human cancer cells. However, the role of this microRNA in glioblastoma (GBM) is presently unclear. In this study, the role of miR‑610 in cell proliferation was investigated in GBM. It was demonstrated that miR‑610 expression is markedly downregulated in GBM cells and GBM tissues compared with normal human astrocytes (NHAs) and normal brain tissue, respectively. Ectopic expression of miR‑610 reduced the proliferation and anchorage‑independent growth of GBM cells, whereas inhibition of miR‑610 promoted this effect. Bioinformatics analysis further revealed cyclin D2 (CCND2) and AKT3, putative tumor promoters, as potential targets of miR‑610. Data from reporter assays showed that miR‑610 directly binds to the 3'‑untranslated region of CCND2 and AKT3 mRNA, and represses their expression at the transcriptional and translational levels. In conclusion, the data provide compelling evidence that miR‑610 functions as an anti‑onco‑miRNA, which is important in inhibiting cell proliferation in GBM, and its anti‑oncogenic effects are mediated chiefly through direct suppression of CCND2 and AKT3 expression.
- Open Access
- 28 July 2014
- Published by Spandidos Publications in Oncology Letters
- Vol. 8 (4) , 1731-1734
Downregulation of GSK3β by miR-544a to maintain self-renewal ability of lung caner stem cells
In order to study the influence and mechanism of miR‑544a on the self‑renewal ability of lung cancer stem cells, TargetScan was used to predict the target gene of miR‑544a. A luciferase reporter system and western blotting were used to validate the target genes identified by TargetScan. 95C and 95D low and high metastatic human lung cancer cells were transfected with miR‑544a, and quantitative polymerase chain reaction (qPCR) was used to verify the miR‑544a expression in these two cell lines. Tumor ball (spheroid) suspension culture was use to study the effects of miR‑544a on lung cancer stem cells. TargetScan predicted that miR‑544a interacted with GSK3β. A luciferase reporter system (F=201.37, P<0.01) and western blot analysis was used to validate that miR‑544a could inhibit the expression of GSK3β, while β‑catenin and CD133 were significantly increased in miR‑544a‑overexpressing 95C and 95D cells (F=9.43, 7.73 and 3.37, respectively; P<0.01). qPCR revealed that miR‑544a was overexpressed in transfected 95C and 95D cells (20.51±0.97 and 15.16±1.38, respectively; F=418.05; P<0.01). miR‑544a‑overexpressing cells formed spheroids in suspension cultures of spheroid single cells. miR‑544a was shown to reduce the expression of GSK3β and activate the Wnt signaling pathway to maintain the self‑renewal ability of lung caner stem cells.
- 28 July 2014
- Published by Spandidos Publications in Oncology Letters
- Vol. 8 (4) , 1731-1734
Open AccessDownregulation of GSK3β by miR-544a to maintain self-renewal ability of lung caner stem cells
In order to study the influence and mechanism of miR‑544a on the self‑renewal ability of lung cancer stem cells, TargetScan was used to predict the target gene of miR‑544a. A luciferase reporter system and western blotting were used to validate the target genes identified by TargetScan. 95C and 95D low and high metastatic human lung cancer cells were transfected with miR‑544a, and quantitative polymerase chain reaction (qPCR) was used to verify the miR‑544a expression in these two cell lines. Tumor ball (spheroid) suspension culture was use to study the effects of miR‑544a on lung cancer stem cells. TargetScan predicted that miR‑544a interacted with GSK3β. A luciferase reporter system (F=201.37, P<0.01) and western blot analysis was used to validate that miR‑544a could inhibit the expression of GSK3β, while β‑catenin and CD133 were significantly increased in miR‑544a‑overexpressing 95C and 95D cells (F=9.43, 7.73 and 3.37, respectively; P<0.01). qPCR revealed that miR‑544a was overexpressed in transfected 95C and 95D cells (20.51±0.97 and 15.16±1.38, respectively; F=418.05; P<0.01). miR‑544a‑overexpressing cells formed spheroids in suspension cultures of spheroid single cells. miR‑544a was shown to reduce the expression of GSK3β and activate the Wnt signaling pathway to maintain the self‑renewal ability of lung caner stem cells.